Showing 65,621 - 65,640 results of 104,200 for search '(( 5 ((((we decrease) OR (a decrease))) OR (mean decrease)) ) OR ( a step decrease ))', query time: 1.30s Refine Results
  1. 65621

    Table_1_Diagnostic Value of Sural Nerve Biopsy: Retrospective Analysis of Clinical Cases From 1981 to 2017.DOCX by Valeria Prada (176235)

    Published 2019
    “…The percentage of hereditary neuropathies had a significant decrease (p = 0.016), while the rate of vasculitic and chronic inflammatory neuropathies increased (p < 0.0001). …”
  2. 65622

    Table_1_Colchicine Effectiveness and Safety in Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Adenitis.pdf by Tatjana Welzel (11753417)

    Published 2021
    “…Colchicine was started at 0.5–1.0 mg/day. DA was captured by physician (PGA) and patient/parent (PPGA) global assessment on a 10 cm visual analog scale, categorized as mild (<2), moderate (2–4), and high (≥5). …”
  3. 65623

    The CCDC66 depletion disrupts endocytosis and membrane recycling near cilia. by Jovana Deretic (13113617)

    Published 2025
    “…<b>(B)</b> Measured is the mean pixel intensity of a circular 5 μm<sup>2</sup> area centered at the ciliary base of each cell in <b>(A)</b>. …”
  4. 65624

    Development and Progression of Diabetic Retinopathy in Adolescents and Young Adults With Type 2 Diabetes: Results From the TODAY Study by Rose Gubitosi-Klug (10513924)

    Published 2021
    “…Three hundred sixty-seven patients with gradable fundus photographs in at least one eye at both assessments were included in analyses of progression of diabetic retinopathy, defined as an increase of three or more steps on the ETDRS scale.</p> <p><b>Results</b>: With mean age of 25.4 ± 2.5 years and diabetes duration of 12.0 ± 1.5 years, participants had a 49% prevalence of any diabetic retinopathy. …”
  5. 65625

    AS101 prevents renal hypertrophy in STZ injected rats. by Itay Israel Shemesh (669254)

    Published 2014
    “…*p<0.01 increase vs. control group. #p<0.01 decrease vs. STZ+PBS group (n = 5 for Control; n = 7 for STZ+PBS; n = 9 for STZ+AS101 LD; n = 8 for STZ+AS101 HD).…”
  6. 65626

    Effects of CANA on metabolites evaluated by metabolomics. by Dan Nakano (8775380)

    Published 2020
    “…Red circle indicates differential metabolites, which determined the condition of >1.5-fold increase with P<0.05 or <0.7-fold decrease with P<0.05. …”
  7. 65627

    Effectiveness of all intervention scenarios. by Yae Jee Baek (9565342)

    Published 2020
    “…We assume the sensitivity of front door screening of 0.5 or 0.7 and the protection rates possibly becoming 0.3, 0.6, or 0.9 as reinforcing protection device. …”
  8. 65628

    Effectiveness of all intervention scenarios. by Yae Jee Baek (9565342)

    Published 2021
    “…We assume the sensitivity of front door screening of 0.5 or 0.7 and the protection rates possibly becoming 0.3, 0.6, or 0.9 as reinforcing protection device. …”
  9. 65629

    PIN1 endocytosis is inhibited in the lobe region by the ROP2 pathway in PCs. by Shingo Nagawa (173932)

    Published 2012
    “…Coexpressing CA-ROP2 suppressed both vesicle formation and decrease of PM signal in <i>rop4 R2i</i> cells (<i>n</i> = 5). …”
  10. 65630

    Effect of siRNA specific for PIASy and E12 in α-SMA regulation in MCs. by Kazuo Torikoshi (150022)

    Published 2012
    “…<p>(A) PIASy mRNA and protein were reduced by transfection of siRNA against PIASy in mouse MCs. …”
  11. 65631

    Data_Sheet_1_Molecular epidemiological characteristics of Mycobacterium leprae in highly endemic areas of China during the COVID-19 epidemic.docx by Jiaojiao Zhou (432827)

    Published 2024
    “…</p>Results<p>There was an 18.97% decrease in the number of counties and districts reporting cases. …”
  12. 65632

    <sup>1</sup>H NMR in Solution and Solid State Structural Study of Lanthanide(III) Cryptates by C. Platas (2978436)

    Published 1999
    “…We present here a detailed structural comparison, both in the solid state and in aqueous solution, of a complete series of lanthanide cryptate complexes of a Schiff base axial macrobicyclic ligand L of general formula [LnL][NO<sub>3</sub>]<sub>3</sub>·<i>x</i>H<sub>2</sub>O (Ln = La−Lu, Y); the macrobicyclic receptor L is an azacryptand N[(CH<sub>2</sub>)<sub>2</sub>NCH−R−CHN(CH<sub>2</sub>)<sub>2</sub>]<sub>3</sub>N (R = <i>m</i>-C<sub>6</sub>H<sub>2</sub>OH-2-Me-5). …”
  13. 65633

    Global mRNA Expression Profiles of <i>set1</i>Δ and <i>H3-K4R</i> Mutant Strains. by Benoit Guillemette (5650312)

    Published 2011
    “…A sliding window average was applied to the data on both axes (window  =  50, step  =  1). …”
  14. 65634

    DataSheet_1_Nationwide Trends of Pediatric Obesity and BMI z-Score From 2017-2021 in China: Comparable Findings From Real-World Mobile- and Hospital-Based Data.docx by Yan Yang (33204)

    Published 2022
    “…The trend of obesity prevalence remained stable with slight decrease, but COVID-19 lockdown caused a significant increase of 1.86% in 2020. …”
  15. 65635

    Mutations at p53 binding sites augment PIK3CA promoter activity. by Snehal M. Gaikwad (279479)

    Published 2013
    “…Representative bioluminescent images of the mice bearing tumors of A2780-MPFT3 cells. Mouse from control and treated group exhibited specific [Fig. 5e3 (pre-treatment)] signals which did not decrease even after two treatments of cisplatin [Fig. 5e3 (post-treatment)].…”
  16. 65636

    Table1_Effect of botanical drugs in improving symptoms of hypertensive nephropathy: Analysis of real-world data, retrospective cohort, network, and experimental assessment.XLSX by Jia-Ming Huan (15185389)

    Published 2023
    “…</p><p>Results: A total of 14 botanical drugs and five symptom communities were obtained from real-world clinical data. …”
  17. 65637

    Image_1_Cardioprotecive Properties of Known Agents in Rat Ischemia-Reperfusion Model Under Clinically Relevant Conditions: Only the NAD Precursor Nicotinamide Riboside Reduces Infa... by Yang Xiao (146335)

    Published 2021
    “…., opiates, benzodiazepines, P2Y<sub>12</sub> antagonist, propofol) need to be identified in preclinical models.</p><p>Methods: Here, we examined the efficacy of promising cardioprotective compounds [fingolimod (Fingo), empagliflozin (Empa), melatonin (Mela) and nicotinamide riboside (NR)] administered i.v. as bolus before start ischemia. …”
  18. 65638

    Effects of siRNA on RET/PTC3 Junction Oncogene in Papillary Thyroid Carcinoma: From Molecular and Cellular Studies to Preclinical Investigations by Hafiz Muhammad Ali (554920)

    Published 2014
    “…Our aim is to demonstrate <i>in vitro</i> and <i>in vivo</i> molecular and cellular effects of siRNA on <i>RET/PTC3</i> knockdown for therapeutic application.First, we established a novel cell line stably expressing <i>RET/PTC3</i> junction oncogene, named RP3 which was found tumorigenic in nude mice compared to NIH/3T3 mouse fibroblasts. …”
  19. 65639

    Data_Sheet_1_Cardioprotecive Properties of Known Agents in Rat Ischemia-Reperfusion Model Under Clinically Relevant Conditions: Only the NAD Precursor Nicotinamide Riboside Reduces... by Yang Xiao (146335)

    Published 2021
    “…., opiates, benzodiazepines, P2Y<sub>12</sub> antagonist, propofol) need to be identified in preclinical models.</p><p>Methods: Here, we examined the efficacy of promising cardioprotective compounds [fingolimod (Fingo), empagliflozin (Empa), melatonin (Mela) and nicotinamide riboside (NR)] administered i.v. as bolus before start ischemia. …”
  20. 65640